The Differential Sensitivity of Human and Rhesus Macaque CCR5 to Small-Molecule Inhibitors of Human Immunodeficiency Virus Type 1 Entry Is Explained by A Single Amino Acid Difference and Suggests A Mechanism of Action for These Inhibitors.
Journal of Virology.
Times cited: 41
Entry inhibitors SCH-C, RANTES, and T-20 block HIV type 1 replication in multiple cell types.
AIDS Research and Human Retroviruses.
Times cited: 47
SCH-C (SCH 351125), an orally bioavailable, small molecule antagonist of the chemokine receptor CCR5, is a potent inhibitor of HIV-1 infection in vitro and in vivo.
Proceedings of the National Academy of Sciences of the United States of America.
Times cited: 303